Target intelligence / Profile preview

U4 small nuclear RNA, pseudogene 80 (RNU4-80P)

Target
RNU4-80P
Molecular classification
Other (non-coding RNA pseudogene)
01

Overview

RNU4-80P, also known as "RNA, U4 small nuclear 80, pseudogene," is a non-coding RNA pseudogene in the human genome. It is a sequence homologous to the functional U4 small nuclear RNA (snRNA) gene but contains mutations or structural features that render it non-functional. The U4 snRNA is an essential component of the major spliceosome involved in pre-mRNA splicing, but RNU4-80P does not produce a functional RNA product and is not known to participate in any biological pathways or disease mechanisms. The existence of U4 snRNA pseudogenes such as RNU4-80P likely reflects reverse transcription and integration events in evolution, but there is no evidence that RNU4-80P itself has any transcriptional activity or clinical relevance as a therapeutic target[1][5]. Key clarifications: - Canonical naming: The target is a pseudogene, not a functional snRNA gene, receptor, enzyme, transporter, or other therapeutic target class. - Therapeutic relevance: No evidence exists that RNU4-80P serves as a drug target, biomarker, or disease-modifying gene; only its functional homologs such as RNU4-2 (U4 snRNA) are disease-relevant and have pathogenic variants associated with neurodevelopmental disorders[4][5]. - Correction: If the query intended to reference a functional U4 snRNA (like RNU4-2), use "U4 small nuclear RNA (RNU4-2)" instead. If the intent was for a therapeutic or clinical target, RNU4-80P is incorrect and not suitable.

Other names
RNU4-80PRNA, U4 small nuclear 80, pseudogene
02

Biological functions

no known function, as it is a pseudogene
03

Disease associations

no described disease association for the pseudogene

Beyond the preview

Go deeper on U4 small nuclear RNA, pseudogene 80 (RNU4-80P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U4 small nuclear RNA, pseudogene 80 (RNU4-80P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call